Written question asked by Nicholas Winterton (Conservative) on Tuesday, 20 November 2001, in the House of Commons. It was due for an answer on Monday, 10 December 2001. It was answered by Lord Hutton of Furness (Labour) on Monday, 10 December 2001 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, what plans he has to (a) alter the remit and (b) review the framework of the National Institute for Clinical Excellence; and if NICE includes the therapeutic requirements of specific diseases in its assessments of the efficacy of individual drugs. - Including ref to 22 November 2001, 375 c416W.

Answer: Mr. Nicholas Winterton: To ask the Secretary of State for Health what plans he has to (a) alter the remit and (b) review the framework of the National Institute for Clinical Excellence; and if NICE includes the therapeutic requirements of specific diseases in its assessments of the efficacy of individual drugs. [17433] Mr. Hutton: I refer the hon. Member to the reply given to the hon. Member for Sutton and Cheam (Mr. Burstow) on 22 November 2001, Official Report, column 416W. The precise methodology used in appraisals of individual therapies is for the National Institute for Clinical Excellence itself, but the institute's recommendations always take account of the specific features of the conditions in which the therapies are to be applied.

Secondary information

Type: Written question
Reference: 376 c717W; 17433
Session: 2001-02
Subjects: Accountability Drugs Functions Medical treatments Reviews National Institute for Clinical Excellence
Link: View this Written question on www.publications.parliament.uk